FT NYSE Arca Biotechnology UE A/ IE00BL0L0H60 /
NAV2024-05-09 | Chg.+0.1130 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
18.1370USD | +0.63% | reinvestment | Equity Worldwide | First Trust Advisors ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020 | - | - | - | - | - | 1.42 | -1.12 | -3.19 | -2.15 | -2.79 | 5.56 | 4.23 | - |
2021 | 4.23 | -4.04 | -4.62 | 2.37 | -0.73 | 5.94 | -2.66 | 3.41 | -4.49 | -0.08 | -5.54 | 3.34 | -3.71% |
2022 | -8.06 | -1.63 | 1.78 | -8.94 | -0.69 | 0.53 | 3.37 | -2.77 | -3.12 | 8.59 | 8.45 | -0.68 | -4.69% |
2023 | 5.92 | -6.00 | 0.86 | -0.96 | -0.46 | -0.27 | 1.90 | -0.70 | -5.23 | -9.19 | 6.46 | 11.64 | +2.19% |
2024 | -5.77 | 1.50 | 1.85 | -6.48 | 3.29 | - | - | - | - | - | - | - | - |
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 16.46% | 18.19% | 16.90% | 21.49% | -% |
Sharpe ratio | -1.20 | 0.92 | -0.43 | -0.29 | - |
Best month | +11.64% | +11.64% | +11.64% | +11.64% | - |
Worst month | -6.48% | -6.48% | -9.19% | -9.19% | - |
Maximum loss | -11.90% | -11.90% | -17.15% | -30.04% | - |
Outperformance | - | - | - | - | - |
All quotes in USD
Performance
YTD | -5.90% | ||
---|---|---|---|
6 Months | +9.70% | ||
1 Year | -3.52% | ||
3 Years | -6.77% | ||
5 Years | - | ||
10 Years | - | ||
Since start | -9.32% | ||
Year | |||
2023 | +2.19% | ||
2022 | -4.69% | ||
2021 | -3.71% |